Vascudyne, Inc.
Vascudyne is a biological tissue engineering company dedicated to revolutionizing healthcare through the development of regenerative therapies. Their mission is to become a global leader in tissue engineering, creating biological tissues for medical needs such as cardiovascular, neurological, wound healing, and subcutaneous implants. They focus on engineering and growing human tissues in various shapes and sizes, using fibrin derived from plasma as a scaffold, with tissue development taking place in GMP manufacturing facilities. Their goal is to improve lives through uncompromising quality, comfort, and longevity.
Industries
Nr. of Employees
small (1-50)
Vascudyne, Inc.
Products
Implantable allogeneic biological tissue grafts (decellularized fibrin-based)
Completely biological, decellularized tissue grafts produced from fibrin scaffolds seeded with human cells and matured to achieve native-like architecture and mechanical properties; intended for implantation in cardiovascular, neurological, wound healing, and subcutaneous indications.
Implantable allogeneic biological tissue grafts (decellularized fibrin-based)
Completely biological, decellularized tissue grafts produced from fibrin scaffolds seeded with human cells and matured to achieve native-like architecture and mechanical properties; intended for implantation in cardiovascular, neurological, wound healing, and subcutaneous indications.
Services
Manufacture of clinical-grade, biologically derived implantable tissues in a GMP environment, including maturation, quality control, and preparation for distribution.
Manufacture of clinical-grade, biologically derived implantable tissues in a GMP environment, including maturation, quality control, and preparation for distribution.
Expertise Areas
- Tissue engineering
- Regenerative medicine
- Allogeneic graft production
- Bioreactor-based cell culture
Key Technologies
- Plasma-derived fibrin scaffolds
- Human cell seeding and expansion
- Bioreactor tissue maturation
- Decellularization techniques